Related content

PEGylated PAMAM Dendrimer-Doxorubicin Conjugates: In Vitro Evaluation and In Vivo Tumor Accumulation

By Zhu Saijie   Hong Minghuang   Zhang Lihong   Tang Guotao   Jiang Yanyan   Pei Yuanying  

Pharmaceutical Research, Vol. 27, Iss. 1, 2010-01 ,pp. : 161-174

Springer Publishing Company

Access to resources Recommend Favorite

In Vitro and in Vivo Metabolism of the Anti-Cancer Agent CI-1040, a MEK Inhibitor, in Rat, Monkey, and Human

By Wabnitz Paul A.   Mitchell David   Wabnitz David A.M.  

Pharmaceutical Research, Vol. 21, Iss. 9, 2004-09 ,pp. : 1670-1679

Springer Publishing Company

Access to resources Recommend Favorite

Dosage Form Development, in Vitro Release Kinetics, and in Vitro–in Vivo Correlation for Leuprolide Released from an Implantable Multi-reservoir Array

By Prescott James   Krieger Timothy   Lipka Sara   Staples Mark  

Pharmaceutical Research, Vol. 24, Iss. 7, 2007-07 ,pp. : 1252-1261

Springer Publishing Company

Access to resources Recommend Favorite

Use of a Dynamic in Vitro Lipolysis Model to Rationalize Oral Formulation Development for Poor Water Soluble Drugs: Correlation with in Vivo Data and the Relationship to Intra-Enterocyte Processes in Rats

By Dahan Arik   Hoffman Amnon  

Pharmaceutical Research, Vol. 23, Iss. 9, 2006-09 ,pp. : 2165-2174

Springer Publishing Company

Access to resources Recommend Favorite

Aqueous-Soluble, Non-Reversible Lipid Conjugate of Salmon Calcitonin: Synthesis, Characterization and In Vivo Activity

By Cheng Weiqiang   Satyanarayanajois Seetharama   Lim Lee-Yong  

Pharmaceutical Research, Vol. 24, Iss. 1, 2007-01 ,pp. : 99-110

Springer Publishing Company

Access to resources Recommend Favorite